These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Clinical Characterization and Predictive Factors for Progression in a Cohort of Patients with Interstitial Lung Disease and Features of Autoimmunity: The Need for a Revision of IPAF Classification Criteria. Bozzao F; Tomietto P; Baratella E; Kodric M; Cifaldi R; Della Porta R; Prearo I; Pirronello SMG; Confalonieri P; Ruaro B; Fischetti F; Fabris B Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109752 [No Abstract] [Full Text] [Related]
23. Clinical effect of progressive pulmonary fibrosis on patients with connective tissue disease-associated interstitial lung disease: a single center retrospective cohort study. Lee JK; Ahn Y; Noh HN; Lee SM; Yoo B; Lee CK; Kim YG; Hong S; Ahn SM; Kim HC Clin Exp Med; 2023 Dec; 23(8):4797-4807. PubMed ID: 37831431 [TBL] [Abstract][Full Text] [Related]
24. The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease. Ma H; Lu J; Song Y; Wang H; Yin S BMC Pulm Med; 2020 Jan; 20(1):6. PubMed ID: 31915006 [TBL] [Abstract][Full Text] [Related]
27. Factors for progressive pulmonary fibrosis in connective tissue disease-related interstitial lung disease. Kim K; Lee J; Jo YS Ther Adv Respir Dis; 2023; 17():17534666231212301. PubMed ID: 37991015 [TBL] [Abstract][Full Text] [Related]
28. CT predictors of outcomes in patients with connective tissue disease and progressive lung fibrosis. Shou AY; Salvatore MM Clin Imaging; 2023 Feb; 94():42-49. PubMed ID: 36493681 [TBL] [Abstract][Full Text] [Related]
29. Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease. Lee JS; Lee EY; Ha YJ; Kang EH; Lee YJ; Song YW Arthritis Res Ther; 2019 Feb; 21(1):58. PubMed ID: 30764869 [TBL] [Abstract][Full Text] [Related]
30. Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Two Italian Referral Centers. Faverio P; Piluso M; De Giacomi F; Della Zoppa M; Cassandro R; Harari S; Luppi F; Pesci A Respiration; 2020; 99(10):838-845. PubMed ID: 33264777 [TBL] [Abstract][Full Text] [Related]
31. Demographic and clinical predictors of progression and mortality in connective tissue disease-associated interstitial lung disease: a retrospective cohort study. Chan C; Ryerson CJ; Dunne JV; Wilcox PG BMC Pulm Med; 2019 Oct; 19(1):192. PubMed ID: 31672127 [TBL] [Abstract][Full Text] [Related]
32. Current perspective of progressive-fibrosing interstitial lung disease. Kishaba T Respir Investig; 2022 Jul; 60(4):503-509. PubMed ID: 35431170 [TBL] [Abstract][Full Text] [Related]
33. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India. Singh P; Thakur B; Mohapatra AK; Padhan P Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423 [TBL] [Abstract][Full Text] [Related]
34. Screening value of lung ultrasound in connective tissue disease related interstitial lung disease. Huang Y; Liu T; Huang S; Qiu L; Luo F; Yin G; Xie Q Heart Lung; 2023; 57():110-116. PubMed ID: 36182861 [TBL] [Abstract][Full Text] [Related]
36. Clinical Characteristics of Connective Tissue Disease-Associated Interstitial Lung Disease in 1,044 Chinese Patients. Hu Y; Wang LS; Wei YR; Du SS; Du YK; He X; Li N; Zhou Y; Li QH; Su YL; Zhang F; Shen L; Weng D; Brown KK; Li HP Chest; 2016 Jan; 149(1):201-8. PubMed ID: 26447566 [TBL] [Abstract][Full Text] [Related]
37. Predictors of mortality in patients with interstitial lung disease treated with corticosteroids: results from a cohort study. Migita K; Arai T; Jiuchi Y; Izumi Y; Iwanaga N; Kawahara C; Suematsu E; Miyamura T; Tsutani H; Kawabe Y; Matsumura R; Mori S; Ohshima S; Yoshizawa S; Suenaga Y; Ogushi F; Kawabata M; Furukawa H; Matsui T; Bito S; Tohma S Medicine (Baltimore); 2014 Nov; 93(26):e175. PubMed ID: 25474431 [TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of natural killer cell depletion in predicting progressive fibrosing interstitial lung disease in idiopathic inflammatory myopathies. Shao C; Xia N; Zhen Y; Zhang X; Yan N; Guo Q Front Immunol; 2024; 15():1404828. PubMed ID: 38745647 [TBL] [Abstract][Full Text] [Related]
39. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year. Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570 [TBL] [Abstract][Full Text] [Related]